MEZOO Co., Ltd.

MEZOO is a South Korean digital healthcare company that specializes in the development, manufacturing, and sales of wearable medical devices and remote patient monitoring (aRPM) platforms. The company focuses on the Internet of Medical Things (IoMT), providing solutions that capture real-time physiological data such as ECG, heart rate, respiration, and body posture for clinical and home use. Founded in 2018 by researchers with backgrounds in biomedical engineering, MEZOO has developed the 'HiCardi' system, which includes wearable biosensors (SmartPatch), mobile applications (SmartView), and centralized monitoring software (LiveStudio). The company is actively expanding its global footprint with regulatory clearances in multiple international markets, including Australia, Japan, and Saudi Arabia, and has received FDA 510(k) clearance for its H100 device.